Literature DB >> 29876867

Stem Cell and Obesity: Current State and Future Perspective.

Moloud Payab1, Parisa Goodarzi2, Najmeh Foroughi Heravani3, Mahdieh Hadavandkhani3, Zeinab Zarei4, Khadijeh Falahzadeh5, Bagher Larijani6, Fakher Rahim7, Babak Arjmand8,9.   

Abstract

Obesity as a worldwide growing challenge is determined by abnormal fat deposition, which may damage general health. Weight loss and control of related risk factors like type2 diabetes, dyslipidemia, hypertension, cardiovascular diseases, and metabolic syndrome is an important concern in obesity management. Different therapeutic approaches such as lifestyle change, medications, and surgery are introduced for obesity treatment. Despite of gaining partially desirable results, the problem is remained unsolved. Therefore, finding a new approach that can overcome previous limitations is very attractive for both researchers and clinicians. Cell-based therapy using adipose-derived stromal cells seems to be a promising strategy to control obesity and related syndromes. To attain this aim, understanding of different type of adipose tissues, main signaling pathways, and different factors involved in development of adipocyte is essential. Recently, several cell-based methods like stem cell administration, brown adipose tissue transplantation, cell lysates and exosomes have been examined on obese mouse models to manage obesity and related disorders. Successful outcome of such preclinical studies can encourage the cell-based clinical trials in the near future.

Entities:  

Keywords:  Adipocyte; Adipose tissue; Animal models; Cell therapy; Mesenchymal stem/stromal cells; Obesity

Mesh:

Year:  2018        PMID: 29876867     DOI: 10.1007/5584_2018_227

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  15 in total

1.  Dyslipidemia Is a Major Factor in Stem Cell Damage Induced by Uncontrolled Long-Term Type 2 Diabetes and Obesity in the Rat, as Suggested by the Effects on Stem Cell Culture.

Authors:  Maryam Masouminia; Robert Gelfand; Istvan Kovanecz; Dolores Vernet; James Tsao; Ruben Salas; Kenny Castro; Leila Loni; Jacob Rajfer; Nestor F Gonzalez-Cadavid
Journal:  J Sex Med       Date:  2018-12       Impact factor: 3.802

2.  The Outcome of Stem Cell-Based Therapies on the Immune Responses in Rheumatoid Arthritis.

Authors:  Peyvand Parhizkar Roudsari; Sepideh Alavi-Moghadam; Mostafa Rezaei-Tavirani; Parisa Goodarzi; Akram Tayanloo-Beik; Forough Azam Sayahpour; Bagher Larijani; Babak Arjmand
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 3.  Therapeutic mesenchymal stromal stem cells: Isolation, characterization and role in equine regenerative medicine and metabolic disorders.

Authors:  Mohamad Al Naem; Lynda Bourebaba; Katarzyna Kucharczyk; Michael Röcken; Krzysztof Marycz
Journal:  Stem Cell Rev Rep       Date:  2020-04       Impact factor: 5.739

Review 4.  Prospect of Stem Cell Therapy and Regenerative Medicine in Osteoporosis.

Authors:  Babak Arjmand; Masoumeh Sarvari; Sepideh Alavi-Moghadam; Moloud Payab; Parisa Goodarzi; Kambiz Gilany; Neda Mehrdad; Bagher Larijani
Journal:  Front Endocrinol (Lausanne)       Date:  2020-07-03       Impact factor: 5.555

Review 5.  Auxiliary role of mesenchymal stem cells as regenerative medicine soldiers to attenuate inflammatory processes of severe acute respiratory infections caused by COVID-19.

Authors:  Peyvand Parhizkar Roudsari; Sepideh Alavi-Moghadam; Moloud Payab; Forough Azam Sayahpour; Hamid Reza Aghayan; Parisa Goodarzi; Fereshteh Mohamadi-Jahani; Bagher Larijani; Babak Arjmand
Journal:  Cell Tissue Bank       Date:  2020-06-25       Impact factor: 1.522

6.  Stem Cells from a Female Rat Model of Type 2 Diabetes/Obesity and Stress Urinary Incontinence Are Damaged by In Vitro Exposure to its Dyslipidemic Serum, Predicting Inadequate Repair Capacity In Vivo.

Authors:  Istvan Kovanecz; Robert Gelfand; Guiting Lin; Sheila Sharifzad; Alec Ohanian; Randy Ricks; Tom Lue; Nestor F Gonzalez-Cadavid
Journal:  Int J Mol Sci       Date:  2019-08-19       Impact factor: 5.923

Review 7.  Metabolomics Analysis of Mesenchymal Stem Cells.

Authors:  Parisa Goodarzi; Sepideh Alavi-Moghadam; Moloud Payab; Bagher Larijani; Fakher Rahim; Kambiz Gilany; Nikoo Bana; Akram Tayanloo-Beik; Najmeh Foroughi Heravani; Mahdieh Hadavandkhani; Babak Arjmand
Journal:  Int J Mol Cell Med       Date:  2019-06-20

8.  Development of a Novel Anti-Obesity Compound with Inhibiting Properties on the Lipid Accumulation in 3T3-L1 Adipocytes

Authors:  Moloud Payab; Shirin Hasani-Ranjbar; Maryam Baeeri; Mahban Rahimifard; Babak Arjmand; Hamed Haghi-Aminjan; Mohammad Abdollahi; Bagher Larijani
Journal:  Iran Biomed J       Date:  2019-11-30

9.  Comprehensive proteomics and functional annotation of mouse brown adipose tissue.

Authors:  Jing Li; Juan Li; Wei-Gang Zhao; Hai-Dan Sun; Zheng-Guang Guo; Xiao-Yan Liu; Xiao-Yue Tang; Zhu-Fang She; Tao Yuan; Shuai-Nan Liu; Quan Liu; Yong Fu; Wei Sun
Journal:  PLoS One       Date:  2020-05-06       Impact factor: 3.240

Review 10.  Zebrafish for Personalized Regenerative Medicine; A More Predictive Humanized Model of Endocrine Disease.

Authors:  Babak Arjmand; Akram Tayanloo-Beik; Najmeh Foroughi Heravani; Setareh Alaei; Moloud Payab; Sepideh Alavi-Moghadam; Parisa Goodarzi; Mahdi Gholami; Bagher Larijani
Journal:  Front Endocrinol (Lausanne)       Date:  2020-07-17       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.